1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Activ8rlives.com Logo

Activ8rlives helps patients monitor their lung function and health at home.

Up and coming health and wellbeing technology company Activ8rlives will be launching two new devices for monitoring lung health at the Mobile World Congress show in Barcelona (25th-28th February 2013).

Self-monitoring at home for people with long-term respiratory conditions
Self-monitoring at home for people with long-term respiratory conditions
PRLog - Feb. 22, 2013 - HUNTINGDON, U.K. -- The Company will be introducing a Peak Expiratory Flow meter and Pulse oximeter, which upload information about the user to their private account on the web-based Activ8rlives system.

Peak Expiratory Flow (PEF) and the related parameter for Forced Expiratory Volume within 1 second (FEV1), are values which report the performance of a person’s lungs.  Most widely used in the management of Asthma, these measurements can also be used by patients with Chronic Obstructive Pulmonary Disease (COPD) and Cystic Fibrosis, to self-monitor their lung function.  A change in function can be an early indication that a person is becoming unwell and needs to seek treatment.

The pulse oximeter is a simple device which is worn on the end of your finger and calculates the degree of oxygen saturation of the blood by measuring small changes in the colour of your blood.  It also calculates your pulse rate.  The system is presently designed to monitor decreases in oxygenation levels for patients who are trying to preserve lung function but will also be used as a screen for those concerned that they may have undiagnosed sleep apnoea – a condition which often affects males in middle age who are overweight.

The development of these new capabilities is one of a series of investments made possible when the company received a Small Business Research Initiative contract from NHS Midlands and East and the Health Enterprise East's second SBRI competition in last year, to develop and the company’s ideas for a home-based test for lung infections.

In the case of the UK’s 9,000 sufferers of Cystic Fibrosis, use of the devices to help with earlier detection and subsequent treatment of recurring bacterial chest infections (known as exacerbations), which are a key symptom of the condition, could lead to an annual cost saving for the NHS of £57m.

Dr Anne Blackwood, CEO of Health Enterprise East said:  “We are really pleased to see Aseptika introduce new technical capabilities to the market at such a large conference such as Mobile World Congress.  It shows that our SBRI programme allows UK SMEs to innovate and that these can quickly result in the introduction of new products for sale to our NHS and for export overseas.”

- ENDS -

About Aseptika (Activ8rlives.com)

Activ8rlives is the brain child of Kevin Auton, who realised the value group support could bring to sustained weight loss after he and his own family decided to work together to lose weight and improve their general health, fitness and wellbeing.

Activ8rlives offers a range of products, from activity monitors through to electronic weighing scales, combined with an exclusive online community programme, which enables members to track their progress and share their successes with other Activ8rlives members.  Activ8rlives.com is free to use and there are no meeting or subscription fees.

For more information visit www.Activ8rlives.com

Health Enterprise East (NHS)

Health Enterprise East Limited (HEE) is the NHS Innovation Hub for the East of England, and assists with accelerating the development and uptake of innovative MedTech products and services that improve the quality of healthcare delivery.

We are committed to improving healthcare through supporting the development of innovative new products and services which meet the needs of the NHS.  This work was commissioned by the Management Board of SBRI East and funded by NHS East of England, the European Regional Development Fund and the Technology Strategy Board.  The views expressed in the publication are those of the author(s) are not necessarily that of the funding partners.


--- End ---

Click to Share

Contact Email:
***@aseptika.co.uk Email Verified
Source:Aseptika Ltd
Zip:PE29 1WA
Location:Huntingdon - Cambridgeshire - United Kingdom
Tags:cystic fibrosis, asthma, Lung Function, Peak flow
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
Click to Share